Here we use an in vivo cross-linking and immunoprecipitation procedure to detect RNA targets of the multifunctional RNAbinding protein polypyrimidine tract-binding protein (PTBP) 2 in mouse testis. Eleven known mRNAs, including Ptbp2 mRNA, 28 RNAs matching intron sequences, and 12 small RNAs and repeat sequences are identified. The specificity of interaction between PTBP2 and its target RNAs was confirmed using RNA interference with mouse N2A cells. Reduction of PTBP2 levels led to decreases in 7 of 10 of the mRNAs, to the repression of alternative splicing of introns, and to reductions in specific miRNAs.
INTRODUCTION
Eukaryotic gene expression is regulated at many different levels, including the epigenetic modification of DNA and chromatin, alternative splicing, nuclear RNA degradation, RNA export from the nucleus, mRNA stability, translation initiation and elongation, and protein stability. For many of the posttranscriptional processes, RNA-binding proteins, such as polypyrimidine tract-binding protein (PTBP), play pivotal roles.
PTBP, also known as heterogeneous nuclear ribonucleoprotein (hnRNP) I, belongs to a multifunctional family of RNA-binding proteins, which acts at several steps during mRNA biogenesis (mRNA splicing, localization, stability, and internal ribosome entry site-directed translation initiation and translation repression) [1] [2] [3] [4] [5] [6] [7] [8] . Two tissue-restricted isoforms of PTBP have been reported in most mammals. PTBP1 appears to be widely expressed, while PTBP2 (also called NPTB or brPTB) is expressed mainly in neurons and testis [9] [10] [11] . In developing neurons, PTBP2 reprograms alternative splicing as it promotes differentiation [7] , while, in glioma cell lines, PTBP2 promotes proliferation and migration [12] . In the mammalian testis, PTBP2 stabilizes mRNAs, such as phosphoglycerate kinase 2 mRNA [11, 13] .
PTBP, initially identified as an alternative splicing factor [5] , binds to a polypyrimidine tract sequence near the 3 0 splice site, as well as to exonic sequences and to introns downstream of regulated exons [5] . The two PTBP proteins themselves are also subject to alternative splicing. Both PTBP1 and PTBP2 exist as several alternative splicing isoforms [5] . PTBP1 protein promotes the skipping of exon 11 in its transcript, producing a frame-shifted mRNA that is degraded by nonsense-mediated decay [14] . Moreover, PTBP1 regulates the splicing of exon 10 in the pre-mRNA of PTBP2 [7] . The skipping of exon 10 introduces a premature termination codon. The PTBP proteins show a binding preference for CU tracts (e.g., UCUUC and CUCUCU, located within a polypyrimidine-rich context in RNAs), and also serve as RNA chaperones that bring distant pyrimidine tracts into proximity [6] . All four RNA binding motifs of PTBP are capable of specific interactions with RNA, making it difficult to define one RNA consensus sequence and to identify RNA targets of PTBP [15] . Previously, we have demonstrated in testis that PTBP2, but not PTBP1, stabilizes the male germ cell-specific phosphoglycerate kinase 2 mRNA by binding to a sequence in its 3 0 untranslated region [11] . To gain a broader perspective of RNA targets for PTBP2 in the testis, we have used an in vivo cross-linking and immunoprecipitation protocol (CLIP). The CLIP assay has proven a powerful tool in the identification of endogenous cellular targets of numerous RNA-binding proteins, such as NOVA, hnRNPA1, Argonaute, and YBX2 (also known as MSY2) [16] [17] [18] [19] . In this procedure, specific RNA-protein complexes are isolated following the covalent cross-linking of RNA and protein in vivo. Stringent washing of the complexes with high salt and SDS removes adventitiously bound molecules and allows identification of directly interacting RNA and proteins. Here we identify PTBP2 RNA targets in both the nucleus and the cytoplasm, and demonstrate that PTBP2 is needed for alternative mRNA splicing and mRNA and miRNA stabilization in the testis.
MATERIALS AND METHODS

Cross-Linking and Immunoprecipitation of PTBP2
A CLIP analysis of PTBP2 was performed with minor modifications of the published protocol [16, 19] . Briefly, seminiferous tubules were incubated with collagenase P to obtain a single-cell suspension. The cells were exposed to ultraviolet light at 400 mJ/cm 2 in 10-cm dishes and lysed by sonication in icecold lysis buffer (13 PBS, 0.1% SDS, 0.5% deoxycholate, 0.5% NP-40). After centrifugation at 10 000 3 g, the soluble extracts were treated with 30 U RQ DNase I (Promega, Madison, WI) and RNAse A (1: 500; USB, Cleveland, OH) for 30 min at 378C, and then centrifuged at 160 000 3 g for 30 min. The supernatants were incubated with 30 lg polyclonal affinity-purified anti-PTBP2 (Abnova, Taiwan) coupled to protein G-Dynabeads (Invitrogen, Carlsbad, CA) overnight at 48C. After intensive washing with lysis buffer and wash buffer (33 PBS, 0.1% SDS, 0.5% deoxycholate, 0.5% NP-40), the cross-linked RNAs were dephosphorylated and ligated to a 3 0 RNA linker. After 5 0 radiolabeling with P
32
, the samples were separated in SDS Bis-Tris gels (Invitrogen) and transferred to nitrocellulose. After 2-h exposure, a labeled region (;70 kD) was cut from the membrane. The RNA was purified, ligated to a 5 0 linker, treated with Turbo DNA-free kit (Ambion, Austin, TX), and amplified by RT-PCR. Concatemerization and TOPO cloning was performed as previously described [16] . All research animals were maintained and used in compliance with the National Research Council's publication, Guide for Care and Use of Laboratory Animals.
Cell Lines, Transfection, and Western Blotting
Mouse N2A cells were grown in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum and 10 U/ml penicillin/ streptomycin. Small interfering RNAs (siRNAs) for PTBP2 [20] , PTBP1 [21] , and KSRP (predesigned by Ambion), and a negative control were synthesized by Ambion or IDT (Coralville, IA). Hiperfect (Qiagen, Valencia, CA) was used to transfect N2A cells with 15 nM siRNA in 24-well plates, following the manufacturer's instructions. After 48 h, the cells were collected and protein extracts were prepared and examined by Western blotting. Western blots and the preparation of tissue culture cell lysates were performed as previously described [13] . Antibodies were used at the following dilutions:
anti-PTBP2 (1:2000; Abnova, Taiwan), anti-b-actin (1:25 000; Sigma, St. Louis, MO) and HRP-conjugated secondary antibodies.
RT-PCR and Real-Time PCR Assays
Total RNA was purified from adhering tissue culture cells using Trizol (Invitrogen) according to the manufacturer's instructions. First-strand complementary DNA was synthesized with random hexamer primers and Superscript III reverse transcriptase (Invitrogen). All real-time PCRs were performed as described previously [19] . Primers are listed in Supplemental Table S1 (available at www.biolreprod.org).
Semiquantitative RT-PCR analyses of microRNA precursors were performed as described previously [19] . Briefly, equal amounts of small RNAs were purified from the CLIP assay (without RNase treatment). The RNAs were polyA tailed, treated with the TurboDNA-free kit (Ambion), and RT-PCR was performed. The expression level of small RNAs was normalized to U6 snoRNA and miR-16. 
Bioinformatics Analysis
Sequences of miRNA precursors were obtained from miRBase (www. mirbase.org), and piRNAs were identified with piRNAbank (http://pirnabank. ibab.ac.in/). The annotation of small RNAs cloned from the CLIP assays was performed with NCBI Blast searches (http://blast.ncbi.nlm.nih.gov) or Blastlike alignment tool (BLAT) available at the UCSC Genome browser (http:// genome.ucsc.edu/). Data were plotted and graphed using Sigmaplot.
RESULTS
Testis Target RNAs of CLIP
Sequence analysis of 51 CLIP targets for PTBP2 has identified a population of RNAs of 14-34 nt that encode 11 known mRNAs, including Ptbp2 mRNA, 28 RNAs matching intron sequences, 5 repeat sequences, 2 intergenic sequences, and 5 small RNAs that are piRNA-or miRNA-related (Table  1) . Consistent with previous reports for the nucleotide-binding preferences for PTBP, most of the PTBP2 CLIP targets contain CU-rich binding elements. Supporting the specificity of the RNA-protein interactions in the PTBP2 CLIP assay, no ribosomal RNA or transfer RNA sequences were identified as targets, and no CLIP RNAs were detected when preimmune serum was substituted for anti-PTBP2 (data not shown).
Among the 11 mRNAs detected, PTBP2 binds to sequences in the 3 0 untranslated regions for six of the mRNAs, and to sequences in the coding regions of five mRNAs. The selfbinding of PTBP2 to a sequence in its exon 5 suggests an autoregulatory feedback loop for PTBP2, as has been reported for PTBP1 [14, 20] . Among the 28 intron sequences bound by PTBP2, 7 were detected more than once. Among this group of intron targets, sequences from the carbohydrate (N acetylglactosamine 4-0) sulfotransferase 9 and cytoplasmic polyadenylation element-binding protein 3 introns were detected three times at overlapping sites, and five other intron sequences (AK134759, 1110004E09, type 1 thrombospondin, AI847670, and coiled-coil domain containing 60) were detected twice (Table 1) . We propose that the repeat identification of certain sequences indicates either an abundance of these mRNAs in the testis or a preferential interaction between PTBP2 and sites within these pre-mRNAs.
Reductions of PTBP2 Lead to Reductions in Target mRNAs
To establish the specificity of the PTBP2 target RNAs by a method independent of the cross-linking and immunoprecipitation procedure, an RNA interference approach was taken.
Since there are no male germ cell culture lines that reliably mimic later germ cell function, and all of the PTBP2 target mRNAs are normally expressed in N2A cells, a mouse brain N2A neuronal cell line was used. Growth of the neuronal cells for 2 days in the presence of siRNAs complementary to PTBP2 reduced PTBP2 levels in duplicate samples to 34% and 59%, respectively, of controls (Fig. 1) . No PTBP2 decreases were seen when a nonspecific siRNA (designated negative control) or a siRNA specific for another RNA-binding protein, KH-type splicing regulatory protein (KHSRP), was substituted for the PTBP2 siRNA. When PTBP1 levels were reduced with a PTBP1-specific siRNA, PTBP2 levels rose to 127% and 207% in duplicate samples, as previously reported (Fig. 1) [21] .
To determine whether decreases in PTBP2 lead to changes in the amounts of the target RNAs, RT-PCR assays of 10 PTBP2 mRNA targets were performed with purified RNAs. With reduced PTBP2, decreases were seen for 7 of 10 of the mRNAs in the N2A cells (Fig. 2) . No reduction in any of the 10 target mRNA kevels was seen with cells incubated with control siRNAs. Although these mRNA decreases were detected in cultured brain cells, based upon the target identification in the testis and the stabilization of specific germ cell mRNAs by PTBP2 [11] , we believe that PTBP2 regulates these additional mRNAs similarly in the testis.
Reductions of PTBP2 Do Not Affect Amounts of Intron Target RNAs, but Splicing Is Altered
Although most of the mRNA targets of PTBP2 decrease with reduced levels of PTBP2, no decreases were seen for several intron sequence targets (Fig. 2) . PTBP1 and PTBP2 are believed to function as alternative splicing factors rather than general splicing factors [5, 7, 20] . Alternative splicing is regulated by binding of a family of activator and repressor proteins to enhancers and silencer elements [5] . Unlike the family of SR proteins, which often serve as splicing activators, PTBP1 is a well-characterized splicing repressor, although a knockdown of PTBP1 causes both exon inclusion and skipping [5, 21] . To assess whether alternative splicing is affected by reductions in PTBP2, we reduced PTBP2 levels in N2A cells to investigate several PTBP2 target introns that had been detected FIG. 1. PTBP2 levels are reduced by RNA interference in N2A cells. siRNAs specific for PTBP2, PTBP1, KHSRP, and a scrambled negative control were transfected into mouse N2A cells. Each transfection was performed in duplicate. After 2 days, protein extracts were prepared and Western blots were probed for PTBP2 with beta-actin as a loading control. The percentage of PTBP2 in each sample was normalized to beta-actin levels, and is indicated below the figure. The density percentages were calculated using the software of the GE Storm System (GE Healthcare BioSciences, Piscataway, NJ) after background has been subtracted using a blank region of the gel. RNA TARGETS OF PTBP2 IN MOUSE TESTIS 437 more than once by CLIP. For the cytoplasmic polyadenylation element-binding protein 3 precursor mRNA, a decrease of PTBP2 leads to the removal of one alternative splicing product with the skipping of exon 8 (the faster migrating band in Fig. 3 , lane 2). Similarly, in cells with reduced levels of PTBP2, an alternative transcript of gene 1110004E09Rik, containing the intron between exons 6 and 7, was not detected (Fig. 3) . The amounts of each of the alternative transcripts were substantially lower than their primary transcripts. Although no alternative splicing bands were detected for the carbohydrate (N acetylglactosamine 4-0) sulfotransferase 9 precursor mRNA, RT-PCR assays revealed 3-fold decreases between exons 2 and 3 in PTBP2-deficient cells, suggesting a role for PTBP2 in the splicing of this transcript also (data not shown). The absence of a new band may indicate that additional splicing factors are required for the alternative splicing. Our results suggest that PTBP2 is required for alternative splicing of some of its targets.
Reductions of PTBP2 Lead to Selective miRNA Reductions
The detection of one miRNA as a putative PTBP2 binding target suggests a possible role of PTBP2 in microRNA metabolism (Table 1) . Generally, in the nucleus, miRNAs are transcribed as pri-miRNAs, which are processed to shorter nucleotide stem-loop structures (pre-miRNAs) by the nuclease, Drosha and DGCR8. In the cytoplasm, these pre-miRNAs are The binding of PTBP2 to pre-miR-188 and pre-miR-133a was established with CLIPlinked real-time PCR. The relative enrichment was calculated by normalizing the quantity of miRNA bound by PTBP2 to that of control miRNA bound by mouse IgG. C) Reduction of PTBP2 leads to a decrease in the miR-133a precursor. N2A cells were transfected with PTBP2 siRNAs, while the control cells were incubated with negative control siRNAs (Ambion).
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processed further to mature miRNAs by the endonuclease, Dicer. Recently, another RNA-binding protein, hnRNPA1, was demonstrated by the CLIP assay to bind specifically to human pri-miR-18a and facilitate its Drosha-mediated processing [17] . The RNA-binding protein, KHSRP, also promotes the biogenesis of a subset of microRNAs [22] . RNA chromatography and mass spectrometry have demonstrated that PTBP1 binds to the CU-rich element of the pri-miR-101-1 stem loop [23] . Other RNA-binding proteins, such as SRRT (also known as ARS2), a component of the nuclear RNA cap-binding complex, and LIN28 also interact with the Drosha microprocessor complex, and facilitate the processing of specific primiRNAs [24, 25] .
Searching the microRNA database for consensus PTBP binding sites in pre-miRNAs, we identified two microRNAs, MIR133A and MIR188, as possible targets (Fig. 4A) . Using real-time PCR assays of RNAs isolated from testis CLIP experiments where the RNase incubation was omitted to allow recovery of longer target RNAs, precursors for MIR133A and MIR188 were immunoprecipitated (Fig. 4B ) (when RNase is used in the CLIP protocol, as in Table 1 , shorter RNA targets are obtained). A control MIR16 precursor, which lacks the PTBP2 consensus RNA-binding sequence, was not immunoprecipitated. In N2A cells with PTBP2 reduced to ;one-third by RNA interference, pre-miR-133a, but not pre-miR-188, was dramatically decreased (Fig. 4C) . No changes were detected for pri-miR-133a, suggesting an involvement of PTBP2 in micro-RNA biosynthesis at the pre-miRNA level. The lack of effect of decreased PTBP2 on the pre-miR-188 suggests that additional RNA binding proteins may be needed for its processing, as seen for MIRLET7A1 (let-7a-1), which is bound by a complex of hnRNPA1 and hnRNPL [24] .
DISCUSSION
In summary, we use here the CLIP assay to identify a number of nuclear and cytoplasmic target RNAs of PTBP2 from the mammalian testis. We find that PTBP2 binds to specific mRNAs and introns, consistent with the multiple subcellular roles of mRNA stabilization for PTBP2 in the cytoplasm and RNA alternative splicing in the nucleus. The CLIP procedure provides a robust and unbiased methodology to ascertain functional RNA-protein interactions in vivo, while also minimizing nonspecific adventitious binding of molecules. The identification of targets of RNA-binding proteins often helps define their roles in the metabolism of a cell or tissue. For multifunctional proteins, such as members of the PTBP family, an extensive literature exists supporting their roles as alternative splicing factors and mRNA stabilization proteins for specific RNAs in many somatic cell types [6] . With the identification of several classes of target RNAs in the testis, it is now possible to begin to understand the importance of PTBP2 in regulating gene expression during spermatogenesis.
